MA25753A1 - THIAZOL IDINEDIONE SALT FOR THE TREATMENT OF DIABETES MELLIUS - Google Patents

THIAZOL IDINEDIONE SALT FOR THE TREATMENT OF DIABETES MELLIUS

Info

Publication number
MA25753A1
MA25753A1 MA26933A MA26933A MA25753A1 MA 25753 A1 MA25753 A1 MA 25753A1 MA 26933 A MA26933 A MA 26933A MA 26933 A MA26933 A MA 26933A MA 25753 A1 MA25753 A1 MA 25753A1
Authority
MA
Morocco
Prior art keywords
mellius
diabetes
salt
treatment
idinedione
Prior art date
Application number
MA26933A
Other languages
French (fr)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA25753A1 publication Critical patent/MA25753A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
MA26933A 2000-06-08 2002-12-04 THIAZOL IDINEDIONE SALT FOR THE TREATMENT OF DIABETES MELLIUS MA25753A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
MA25753A1 true MA25753A1 (en) 2003-04-01

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26933A MA25753A1 (en) 2000-06-08 2002-12-04 THIAZOL IDINEDIONE SALT FOR THE TREATMENT OF DIABETES MELLIUS

Country Status (23)

Country Link
EP (1) EP1296980A1 (en)
JP (1) JP2003535862A (en)
KR (1) KR20030007918A (en)
CN (1) CN1443186A (en)
AP (1) AP2002002673A0 (en)
AU (1) AU2001264078A1 (en)
BG (1) BG107357A (en)
BR (1) BR0111536A (en)
CA (1) CA2411065A1 (en)
CZ (1) CZ20023966A3 (en)
DZ (1) DZ3382A1 (en)
EA (1) EA200300005A1 (en)
GB (1) GB0014006D0 (en)
HU (1) HUP0301137A3 (en)
IL (1) IL153279A0 (en)
MA (1) MA25753A1 (en)
MX (1) MXPA02012100A (en)
NO (1) NO20025883L (en)
OA (1) OA12284A (en)
PL (1) PL360592A1 (en)
SK (1) SK17142002A3 (en)
WO (1) WO2001094344A1 (en)
ZA (1) ZA200209954B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (en) * 2005-07-22 2007-02-01 Ratiopharm Gmbh New salts of rosiglitazone
WO2008091624A2 (en) * 2007-01-22 2008-07-31 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (en) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Method of preparing a derivative of benzimidazole
WO2010021745A2 (en) * 2008-08-21 2010-02-25 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
GB0014006D0 (en) 2000-08-02
BR0111536A (en) 2003-07-01
CZ20023966A3 (en) 2003-04-16
AP2002002673A0 (en) 2002-12-31
NO20025883L (en) 2003-02-03
JP2003535862A (en) 2003-12-02
EA200300005A1 (en) 2003-04-24
NO20025883D0 (en) 2002-12-06
IL153279A0 (en) 2003-07-06
HUP0301137A2 (en) 2003-08-28
WO2001094344A1 (en) 2001-12-13
ZA200209954B (en) 2003-10-10
PL360592A1 (en) 2004-09-20
AU2001264078A1 (en) 2001-12-17
BG107357A (en) 2003-08-29
DZ3382A1 (en) 2001-12-13
OA12284A (en) 2003-11-10
CN1443186A (en) 2003-09-17
CA2411065A1 (en) 2001-12-13
MXPA02012100A (en) 2003-04-25
SK17142002A3 (en) 2003-10-07
KR20030007918A (en) 2003-01-23
EP1296980A1 (en) 2003-04-02
HUP0301137A3 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
FR22C1033I1 (en) Use of dihydroimidazolones for the treatment of dogs
ATE344253T1 (en) THIAZOLE DERIVATIVES FOR THE TREATMENT OF PPAR-LATED DISEASES
MA25823A1 (en) COMPOSITIONS FOR THE TREATMENT OF WATER.
DZ2936A1 (en) New modified release composition for the treatment of diabetes.
DZ3500A1 (en) PHENETHANOLAMINE DERIVATIVES FOR THE TREATMENT OF RESPIRATORY DISEASES
DE60019158D1 (en) NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF HERZARRYTHMIES
CH1143977H1 (en) 2-Oxy-benzoxazine-4-ones for the treatment of obesity
MA26951A1 (en) PYRAZOLE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES
MA25847A1 (en) COMPOSITION FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION.
DZ3014A1 (en) Medicines for the treatment of hypertension.
DE60239220D1 (en) ClC-2 CANAL OPENER FOR THE TREATMENT OF STOMACH OR DARM ULCUS
FR2786390B1 (en) CORRECTION COTYL FOR USE IN THE TREATMENT OF HIP CONDITIONS
FR2860154B1 (en) COMPOSITION FOR THE TREATMENT OF MALE BREATH
MA25753A1 (en) THIAZOL IDINEDIONE SALT FOR THE TREATMENT OF DIABETES MELLIUS
FR2835851B1 (en) COMPOSITION FOR THE TREATMENT OF MAGNESIUM ALLOYS
FR2800614B1 (en) COMPOSITION FOR THE TREATMENT OF RESPIRATORY INFECTIONS
MA25852A1 (en) METHOD FOR THE TREATMENT OF INFLAMMATION.
FR2881130B1 (en) REACTOR FOR THE TREATMENT OF WATER FOR ITS POTABILIZATION
MA26117A1 (en) NEW COMPOUND FOR THE TREATMENT OF IMPOTENCE
DE60005685D1 (en) OXAZINOCARBAZOLE FOR THE TREATMENT OF CNS DISEASES
FR2868312B1 (en) PATCH FOR THE TREATMENT OF LIP
DE60124093D1 (en) S-methyl-dihydro-ziprasidone for the treatment of eye diseases.
FR2849599B1 (en) USE OF KYNURENINE-3-HYDROXYLASE INHIBITORS FOR THE TREATMENT OF DIABETES
FR2806293B1 (en) SCLERAL IMPLANTS FOR THE TREATMENT OF RETINE DISCOLUTION
FR2884716B1 (en) USE OF AZITHROMYCIN FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF OCULAR INFECTIONS